The second is a License Agreement granting Everest the exclusive license to develop, register and commercialize Lerodalcibep, a novel, small protein-binding, third-generation PCSK9 inhibitor, which is ...

However, Nike chief financial officer Matt Friend warned on the company's earnings call that it now expected the annual cost ...

In an era where data security is paramount for the survival and reputation of businesses, cloud security remains at the ...